EIF2A and carcinoma of esophagus: The EIF2A locus is amplified in patients with lung and head and neck squamous cell carcinoma (SCC) as well as esophageal carcinoma (3), and elevated eIF2A levels have been associated with poor prognosis in breast cancer (18).